Hidradenitis Suppurativa in Patients with Skin of Color: Emerging Therapies and Strategies for Effective Management
Hidradenitis suppurativa (HS) remains one of the most challenging chronic inflammatory diseases seen in dermatology. At the 2025 Skin Of Color Update conference in New York City, Dr. Tiffany Mayo led a case-based discussion on emerging therapies and management strategies for HS, with an emphasis on patients with skin of color.
HS affects between 0.1-4% of the population and is more common in …
Hidradenitis suppurativa (HS) remains one of the most challenging chronic inflammatory diseases seen in dermatology. At the 2025 Skin Of Color Update conference in New York City, Dr. Tiffany Mayo led a case-based discussion on emerging therapies and management strategies for HS, with an emphasis on patients with skin of color.
HS affects between 0.1-4% of the population and is more common in … 
Last September, a co-resident and I had the opportunity to attend the annual congress of the European Academy of Dermatology and Venerology (EADV) in Amsterdam, The Netherlands. With over 17,300 attendees from over 50+ countries and a substantial contingent of “delegates” from Europe, Asia, and Africa, this was a truly diverse experience that showcased the best of dermatology from around the …